What is iSpecimen Inc Annual Revenue?

iSpecimen Inc Annual Revenue fell 3.75%, in the last year to $9.93 M. Its sector's average revenue growth for the last fiscal year was 0.9%.

What is iSpecimen Inc Annual Net Profit?

iSpecimen Inc Annual Net Profit fell 8.97% in the last year to $11.1 M. Its sector's average net profit growth for the last fiscal year was -15.71%.

What is iSpecimen Inc Price to Earning Ratio?

iSpecimen Inc Price to Earning Ratio is -0.13, which is negative.

What is iSpecimen Inc Stock Price?

iSpecimen Inc Stock Price fell 79.85% and underperformed its sector by 91.21% in the past year.

What is iSpecimen Inc Quarterly Revenue?

iSpecimen Inc Quarterly Revenue fell 4.17% YoY to $2.66 M. Its sector's average revenue growth YoY for the quarter was 3.3%.

What is iSpecimen Inc Quarterly Net profit?

iSpecimen Inc Quarterly Net profit rose 31.8% YoY to $1.44 M. Its sector's average net profit growth YoY for the quarter was -49.02%.

What is iSpecimen Inc Debt to Equity Ratio?

iSpecimen Inc Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is iSpecimen Inc Return on Equity(ROE)?

iSpecimen Inc Return on Equity(ROE) for the last financial year was -73.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is iSpecimen Inc Mutual Fund Holding?

iSpecimen Inc Mutual Fund Holding increased by 2.46% in the last quarter to 3.7.

What is iSpecimen Inc Interest Coverage Ratio?

iSpecimen Inc Interest Coverage Ratio is -47.09, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is iSpecimen Inc Institutional Holding?

iSpecimen Inc Institutional Holding increased by 0.86% in the last quarter to 3.71.

How is the iSpecimen Inc today?

The iSpecimen Inc today is trading in the down by -0.75% at 1.33.

How has iSpecimen Inc performed historically?

The iSpecimen Inc is currently trading down -0.75% on an intraday basis in the past week the index rose 2.31%. The index has been down -66.33% in the past quarter and fell -79.85% in the past year. You can view this in the overview section.

iSpecimen Inc XNAS: ISPC

iSpecimen Inc Live Share Price Today, Share Analysis and Chart

Name: iSpecimen Inc: Is Infosys Ltd. worth buying?
Item: iSpecimen Inc
Rating: 1.38375
Author: Trendlyne DVM scores

Download real time

1.33 -0.01 (-0.75%)

New 52W Low in past week

22,645 XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

iSpecimen Inc Key Metrics

My Metrics

Select

Market Capitalization Low in industry Unavailable in chosen country	1.3
PE TTM Negative PE TTM Unavailable in chosen country	-0.1
Price to Book Low in industry Unavailable in chosen country	0.3
Institutional holding current Qtr % Low in industry Unavailable in chosen country	3.7
Revenue Growth Qtr YoY % Negative Revenue Growth Qtr YoY % Unavailable in chosen country	-4.2
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	0.7
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	31.8
Net Profit TTM Growth % Below industry Median Unavailable in chosen country	6.5
Operating Profit Margin Qtr % Negative Operating Profit Margin Qtr % Unavailable in chosen country	-64.1
Operating Profit Margin TTM % Negative Operating Profit Margin TTM % Unavailable in chosen country	-93.9
Piotroski Score Below industry Median Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	-68.4
ROE Annual % Negative ROE Annual % Unavailable in chosen country	-73.9
RoA Annual % Negative RoA Annual % Unavailable in chosen country	-54.9

All financials are in USD Million and price data in USD

Not Eligible

Mid Valuation

31.0 / 100

Technically Bearish

24.4 / 100

1Yr Price target upside is 126%

1 analysts

Check Before You Buy

Check P/E Buy Sell Zone

This stock has negative PE

iSpecimen Inc Stock Price Analysis

Day Price Range -0.8% 1 Day return Unavailable in chosen country	1.3 (LTP) 1.31.4 LowHigh
Week Price Range 2.3% 1 Week return Unavailable in chosen country	1.3 (LTP) 1.21.4 LowHigh
Month Price Range -32.1% 1 Month return Unavailable in chosen country	1.3 (LTP) 1.23 LowHigh
52 Week Price Range -79.8% 1 Year return Unavailable in chosen country	1.3 (LTP) 1.211.8 LowHigh

View full Share Price History

iSpecimen Inc Live Price Chart

Switch to TradingView

Fetching data ...

iSpecimen Inc Stock Analysis

iSpecimen Inc stock analysis with key metrics, changes, and trends.

iSpecimen Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$9.93 M	3.75%	negative	Annual Revenue fell 3.75%, in the last year to $9.93 M. Its sector's average revenue growth for the last fiscal year was 0.9%.
Annual Net Profit	$11.1 M	8.97%	negative	Annual Net Profit fell 8.97% in the last year to $11.1 M. Its sector's average net profit growth for the last fiscal year was -15.71%.
Price to Earning Ratio	-0.13	-	negative	Price to Earning Ratio is -0.13, which is negative.
Stock Price	$1.33	-79.85%	negative	Stock Price fell 79.85% and underperformed its sector by 91.21% in the past year.
Quarterly Revenue	$2.66 M	4.17%	negative	Quarterly Revenue fell 4.17% YoY to $2.66 M. Its sector's average revenue growth YoY for the quarter was 3.3%.
Quarterly Net profit	$1.44 M	31.8%	positive	Quarterly Net profit rose 31.8% YoY to $1.44 M. Its sector's average net profit growth YoY for the quarter was -49.02%.
Debt to Equity Ratio	0.02	-	positive	Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	-73.87 %	-73.87%	negative	Return on Equity(ROE) for the last financial year was -73.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	3.70 %	2.46%	positive	Mutual Fund Holding increased by 2.46% in the last quarter to 3.7.
Interest Coverage Ratio	-47.09	-	negative	Interest Coverage Ratio is -47.09, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).
Institutional Holding	3.71 %	0.86%	positive	Institutional Holding increased by 0.86% in the last quarter to 3.71.

VIEW LESS

Loading data..

iSpecimen Inc - Company Profile

What does iSpecimen Inc do?

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.

iSpecimen Inc Management structure

All Gross Remunerations are in USD

Ms. Katharyn Field

President

2025

Gross Remuneration

Year

iSpecimen Inc Board of directors

All Gross Remunerations are in USD

Mr. Richard Paolone

Chairman of the Board

2025

Gross Remuneration

Year

Ms. Siyun Yang

Independent Director

2025

Gross Remuneration

Year

iSpecimen Inc Live Share Price Today, Share Analysis and Chart

New 52W Low in past week

iSpecimen Inc Key Metrics

Market Capitalization

PE TTM

Price to Book

ROE Annual %

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

RoA Annual %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

Market Capitalization

PE TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

iSpecimen Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

iSpecimen Inc Live Price Chart

iSpecimen Inc Stock Analysis

iSpecimen Inc stock analysis with key metrics, changes, and trends.

Annual Revenue fell 3.75%, in the last year to $9.93 M. Its sector's average revenue growth for the last fiscal year was 0.9%.

Annual Net Profit fell 8.97% in the last year to $11.1 M. Its sector's average net profit growth for the last fiscal year was -15.71%.

Price to Earning Ratio is -0.13, which is negative.

Stock Price fell 79.85% and underperformed its sector by 91.21% in the past year.

Quarterly Revenue fell 4.17% YoY to $2.66 M. Its sector's average revenue growth YoY for the quarter was 3.3%.

Quarterly Net profit rose 31.8% YoY to $1.44 M. Its sector's average net profit growth YoY for the quarter was -49.02%.

Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was -73.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding increased by 2.46% in the last quarter to 3.7.

Interest Coverage Ratio is -47.09, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding increased by 0.86% in the last quarter to 3.71.

iSpecimen Inc - Company Profile

What does iSpecimen Inc do?

iSpecimen Inc Management structure

Ms. Katharyn Field

President

iSpecimen Inc Board of directors

Mr. Richard Paolone

Chairman of the Board

Ms. Siyun Yang

Independent Director

iSpecimen Inc FAQ

How is iSpecimen Inc today?

iSpecimen Inc today is trading in the red, and is down by -0.75% at 1.33.

How has iSpecimen Inc performed historically?

iSpecimen Inc is currently trading down -0.75% on an intraday basis. In the past week the stock rose 2.31%. stock has been down -66.33% in the past quarter and fell -79.85% in the past year. You can view this in the overview section.